American Healthcare REIT, Inc. financial data

Symbol
AHR on NYSE
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 78% % -33%
Return On Equity 2.6% %
Return On Assets 1.5% %
Operating Margin 18% % 4.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 188,028,542 shares 18%
Entity Public Float $5,992,308,000 USD 536%
Weighted Average Number of Shares Outstanding, Basic 166,055,466 shares 27%
Weighted Average Number of Shares Outstanding, Diluted 166,849,603 shares 28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,260,123,000 USD 9.1%
Revenue from Contract with Customer, Excluding Assessed Tax $2,094,506,000 USD 11%
General and Administrative Expense $58,735,000 USD 23%
Costs and Expenses $2,096,360,000 USD 8%
Operating Income (Loss) $415,160,000 USD 14%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $48,647,000 USD
Income Tax Expense (Benefit) $22,171,000 USD -1394%
Net Income (Loss) Attributable to Parent $69,806,000 USD
Earnings Per Share, Basic 0.42 USD/shares
Earnings Per Share, Diluted 0.42 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $114,836,000 USD 50%
Inventory, Net $18,838,000 USD -3.3%
Operating Lease, Right-of-Use Asset $135,399,000 USD -17%
Intangible Assets, Net (Excluding Goodwill) $253,236,000 USD 57%
Goodwill $234,942,000 USD 0%
Assets $5,426,226,000 USD 21%
Deferred Income Tax Liabilities, Net $17,876,000 USD 22%
Liabilities $2,065,611,000 USD -5.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,104,000 USD 16%
Retained Earnings (Accumulated Deficit) $1,559,279,000 USD -6.9%
Stockholders' Equity Attributable to Parent $3,320,638,000 USD 47%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,360,615,000 USD 46%
Liabilities and Equity $5,426,226,000 USD 21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $60,616,000 USD
Net Cash Provided by (Used in) Financing Activities $23,776,000 USD -153%
Net Cash Provided by (Used in) Investing Activities $32,776,000 USD -528%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $151,753,000 USD 23%
Interest Paid, Excluding Capitalized Interest, Operating Activities $20,715,000 USD -42%
Deferred Tax Assets, Valuation Allowance $62,930,000 USD -27%
Operating Lease, Liability $135,603,000 USD -18%
Depreciation $156,390,000 USD 3.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $70,214,000 USD
Lessee, Operating Lease, Liability, to be Paid $210,729,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $29,058,000 USD -5.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $28,106,000 USD -9.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.0585 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $75,126,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Three $29,467,000 USD -7.2%
Deferred Tax Assets, Operating Loss Carryforwards $74,144,000 USD 7.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $28,563,000 USD -9.9%
Operating Lease, Payments $7,887,000 USD -11%
Additional Paid in Capital $4,880,169,000 USD 31%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $30,319,000 USD 8.5%
Depreciation, Depletion and Amortization $41,114,000 USD -3.9%
Deferred Tax Assets, Net of Valuation Allowance $103,745,000 USD 2.8%
Interest Expense $85,775,000 USD -33%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%